Insider: Congleton Jon Chief Executive Officer - Mineralys Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 639,151 | 0 | 639,151 |
| Value | $16,771,322.24 | $0.00 | $16,771,322.24 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/12/2026 | DDS | 7,117 | Direct | COM | $33.15 | $235,932.11 | 639,151 |
| 01/12/2026 | DDS | 9,119 | Direct | COM | $32.21 | $293,707.49 | 646,268 |
| 11/11/2025 | DDS | 8,862 | Direct | COM | $42.31 | $374,946.79 | 809,637 |
| 11/11/2025 | DDS | 12,806 | Direct | COM | $41.64 | $533,235.44 | 818,499 |
| 11/11/2025 | DDS | 4,000 | Direct | COM | $43.50 | $173,983.60 | 805,637 |
| 11/11/2025 | DDS | 29,207 | Direct | COM | $45.20 | $1,320,165.16 | 776,430 |
| 11/11/2025 | DDS | 32,850 | Direct | COM | $46.89 | $1,540,211.67 | 631,305 |
| 11/11/2025 | DDS | 112,275 | Direct | COM | $45.83 | $5,145,956.21 | 664,155 |
| 10/13/2025 | DDS | 13,548 | Direct | COM | $42.63 | $577,544.47 | 832,857 |
| 10/13/2025 | DDS | 1,552 | Direct | COM | $43.03 | $66,782.40 | 831,305 |
| 07/11/2025 | DDS | 15,884 | Direct | COM | $14.51 | $230,430.78 | 846,405 |
| 04/11/2025 | DDS | 15,319 | Direct | COM | $12.19 | $186,802.95 | 862,289 |
| 01/13/2025 | DDS | 18,333 | Direct | COM | $9.06 | $166,082.31 | 877,608 |
| 10/11/2024 | DDS | 15,271 | Direct | COM | $13.52 | $206,433.38 | 895,941 |
| 06/20/2024 | DDS | 14,940 | Direct | COM | $11.73 | $175,237.24 | 926,958 |
| 06/18/2024 | DDS | 16,607 | Direct | COM | $11.99 | $199,073.09 | 941,898 |
| 06/17/2024 | DDS | 17,766 | Direct | COM | $12.25 | $217,711.67 | 958,505 |
| 06/14/2024 | DDS | 16,229 | Direct | COM | $12.52 | $203,162.74 | 976,271 |
| 06/13/2024 | DDS | 39,961 | Direct | COM | $12.74 | $509,027.21 | 992,500 |
| 06/12/2024 | DDS | 16,607 | Direct | COM | $12.77 | $212,013.27 | 1,032,461 |
| 11/22/2023 | AAP | 4,250 | Direct | COM | $5.97 | $25,355.93 | 1,049,068 |
| 09/06/2023 | AAP | 2,250 | Direct | COM | $12.08 | $27,180.00 | 1,044,818 |
| 08/17/2023 | AAP | 2,250 | Direct | COM | $12.10 | $27,225.00 | 1,042,568 |
| 08/11/2023 | AAP | 2,000 | Direct | COM | $12.89 | $25,780.00 | 1,040,318 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research